Metabolic reprogramming and disease progression in cancer patients
Laura Torresano(Consejo Superior de Investigaciones Científicas), José M. Cuezva(Instituto de Salud Carlos III), Fulvio Santacatterina(Universidad Autónoma de Madrid), Cristina Nuevo‐Tapioles(Centro de Biología Molecular Severo Ochoa)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
February 11, 2020
Cited by 73
Related Papers
Mitochondrial ROS Production Protects the Intestine from Inflammation through Functional M2 Macrophage Polarization
|Cell Reports|2017|195
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
|Oncogenesis|2013|80
Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state
|Oncotarget|2015|65
MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
|Stem Cell Reports|2018|38